Policy & Ethics

Some twenty-five years ago, two couples underwent IVF treatment at the same facility: Deborah Perry-Rogers and her husband and Donna Fasano and her husband. The Perry-Rogers are Black; the Fasanos are white. Mrs.

The Loper Bright decision has received much attention, as it should. It was a momentous decision. Some writers have said it gives judges the power to decide what science regulators should use – it does not.

Join Cameron English and  Dr. Chuck Dinerstein on Episode 101 of the Science Dispatch podcast as they discuss:

             

Medicare Advantage, the form of Medicare where insurance companies take the risk of monetary losses while providing the same care as traditional Medicare but at a lower cost to beneficiaries, now provides the majority of care to Medicare-eligible

A modified version of this article appears in Harvard’s Bill of Health, which you can find here.

I’ve written in the past about upcoding in Medicare Advantage, where insurance companies document

For decades, HIV sufferers were bereft of effective treatment.  In 2001, five years after their tenofovir disoproxil fumarate (TDF) drugs were patented, Gilead Pharmaceuticals received FDA approval, and the drugs became prescribable.

Before jumping into this, let me ensure we are all on the same page regarding the four ethical pillars.